RETINAL DEGENERATION
Clinical trials for RETINAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new RETINAL DEGENERATION trials appear
Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug hopes to slow blindness in rare genetic disease
Disease control Recruiting nowThis study tests an experimental drug called VP-001 for people with a rare inherited eye disease that causes vision loss (retinitis pigmentosa linked to the PRPF31 gene). The drug is injected into the eye and aims to slow or stop further vision decline. Sixteen adults who have al…
Matched conditions: RETINAL DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New camera peers deeper into the eye than ever before
Knowledge-focused Recruiting nowThis study uses high-resolution and high-speed cameras to take detailed pictures of the eye. The goal is to see tiny structures that regular eye exams miss, which could help doctors better understand diseases like glaucoma, macular degeneration, and diabetes-related eye problems.…
Matched conditions: RETINAL DEGENERATION
Phase: NA • Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC